Abstract:What's new? Chromosomal aneuploidy, reflecting alterations in chromosome number, is a well‐known feature of cancer. However, varying definitions of aneuploidy and inferences from sequencing‐ and array‐based approaches using bulk DNA have limited its characterization. Here, the authors analyzed chromosome number using single‐cell cytogenetic data from 83,862 tumors, representing 112 different tumor types. Aberrations in chromosome number split into two major clusters, one featuring near‐diploid neoplasms and the other neoplasms with extensive aneuploidy and whole genome doubling. Single‐cell analyses further reveal extensive heterogeneity in chromosomal aneuploidy in both benign and malignant tumors, with certain tumor types potentially utilizing shared pathogenetic mechanisms. Chromosomal aneuploidy, that is, numerical chromosome aberrations, is one of the molecular hallmarks of cancer. However, when neoplasms are studied with sequencing‐ and array‐based approaches, chromosome numbers and ploidy states are typically inferred from bulk DNA data. Furthermore, published molecular estimates of neoplasia‐associated aneuploidy often also include genomic imbalances resulting from various types of structural rearrangement, which likely result from other mechanisms than numerical chromosome aberrations. We thus analyzed chromosome numbers using single‐cell cytogenetic data from 83,862 tumors, and show that both benign and malignant tumors are highly heterogeneous with regard to deviations from the normal, diploid state. Focusing on the chromosome numbers in 112 specific tumor types, defined by both exact morphologic diagnosis and organ location and from which data from ≥50 cases were available, we found two major clusters: one predominated by near‐diploid neoplasms and one by neoplasms with extensive aneuploidy and one or more whole genome doublings. The former cluster included most benign solid tumors, myeloid neoplasms, and malignant gene fusion‐associated solid tumors, whereas the latter was predominated by malignant solid tumors and lymphomas. For 16 malignant tumor types, the distribution of chromosome numbers could be compared to TCGA ploidy level data. Cytogenetic and molecular data correlated well, but the former indicates a higher level of clonal heterogeneity. The results presented here suggest shared pathogenetic mechanisms in certain tumor types and provide a reference for molecular analyses.

Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene

Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas

A highly malignant case of neuroblastoma with substantial increase of single-nucleotide variants and normal mismatch repair system: A case report.

DNA copy number profiles and systems biology connect chromatin remodeling and DNA repair in high-risk neuroblastoma

Intercellular extrachromosomal DNA copy number heterogeneity drives cancer cell state diversity

Pivotal role of biallelic frequency analysis in identifying copy number alterations using genome-wide methods in tumors with a high level of aneuploidy

Genome-wide Analysis of Neuroblastomas Using High-Density Single Nucleotide Polymorphism Arrays.

Aneuploidy in neoplasia: Single‐cell data on 83,862 tumors

A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations

Intercellular extrachromosomal DNA copy-number heterogeneity drives neuroblastoma cell state diversity

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance

Abstract 4338: A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution

Single-cell transcriptome sequencing reveals tumor heterogeneity in family neuroblastoma

Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma

Genomic Analysis-Integrated Whole-Exome Sequencing of Neuroblastomas Identifies Genetic Mutations in Axon Guidance Pathway

Cytogenomic Characterization of Murine Neuroblastoma Cell Line Neuro-2a and Its Two Derivatives Neuro-2a TR-Alpha and Neuro-2a TR-Beta

Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma

A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity